journal Journal For International Medical Graduates Journal For International Medical Graduates California Institute of Behavioral Neurosciences and Psychology US https://www.cibnp.com 2832-9864 137 Articles Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations With Statin Therapy: A Systematic Review Khalid Javed Javed Khalid kjaved0611@gmail.com Prabhleen Kaur Manshahia Manshahia Prabhleen Kaur manshahiapk065@gmail.com Shamsun Nahar Nahar Shamsun shamsun.nahar.dmc@gmail.com Srishti Kanda Kanda Srishti srishtikanda5@gmail.com Uzair Chatha Chatha Uzair uzairchatha28@gmail.com Victor A. Odoma Odoma Victor A. odomavictorameh@gmail.com Aakanksha Pitliya Pitliya Aakanksha bubblypitliya@gmail.com Esraa M. AlEdani AlEdani Esraa M. esraaaledani0gmail.com Japneet Bhangu Bhangu Japneet japneetbhangu98@gmail.com Lubna Mohammed Mohammed Lubna doclubna23@gmail.com California Institute of Behavioral Neurosciences and Psychology (United States) https://ror.org/01ytd2n62 26 09 2023 Received: 2692023 Copyright (c) 2023 Journal For International Medical Graduates 2023 Journal For International Medical Graduates COPD statins inflammation chronicmobstructive pulmonary disease exacerbations emphysema albuterol Ajmera M, Shen C, Sambamoorthi, U: Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study. Drugs Real World Outcomes. 2017, 4:9-19. 10.1007/s40801-016-0101-6 Criner GJ, Connett JE, Aaron SD, et al.: Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD. N Engl J Med. 2014, 370:2201–10. 10.1056/nejmoa1403086 Freyberg J, Landt EM, Afzal S, Nordestgaard BG, Dahl M: Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study. ERJ Open Res. 2022, 9:00496–2022. 10.1183/23120541.00496-2022 Soyseth V, Brekke PH, Smith P, Omland T: Statin use is associated with reduced mortality in COPD. European Respiratory Journal. 2006, 29:279–83. 10.1183/09031936.00106406 Mortensen EM, Copeland LA, Pugh MJV, Restrepo MI, de Molina RM, Nakashima B, Anzueto A: Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res. 2009, 10:. 10.1186/1465-9921-10-45 Zhang W, Zhang Y, Li C-W, Jones P, Wang C, Fan Y: Effect of Statins on COPD. Chest. 2017, 152:1159–68. 10.1016/j.chest.2017.08.015 Maneechotesuwan K, Wongkajornsilp A, Adcock I, et al.: Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD. 2015, 2015:1164-1176. 10.1378/chest.14-3138 Raymakers AJN, Sadatsafavi M, Sin DD, De Vera MA, Lynd LD: The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD. Chest. 2017, 152:486–93. 10.1016/j.chest.2017.02.002 Rossi A, Inciardi RM, Rossi A, et al.: Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial. Pulmonary Pharmacology & Therapeutics. 2017, 44:16–23. 10.1016/j.pupt.2017.03.001 Balaguer C, Peralta A, Ríos Á, et al.: Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial. Contemporary Clinical Trials Communications. 2016, 2:91–6. 10.1016/j.conctc.2015.12.008 Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10.1186/s13643-021-01626-4 Petty TL: The history of COPD. International Journal of COPD. 2006, 1:3–14. 10.2147/copd.2006.1.1.3 Fortis S, Quibrera PM, Comellas AP, et al.: Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023, 163:502–14. 10.1016/j.chest.2022.11.009 Wang M-T, Lo Y-W, Tsai C-L, Chang L-C, Malone DC, Chu C-L, Liou J-T: Statin Use and Risk of COPD Exacerbation Requiring Hospitalization. The American Journal of Medicine. 2013, 126:598-606.e2. 10.1016/j.amjmed.2013.01.036 Fehrenbach H: Respir Res. 2001, 2:33. 10.1186/rr36 Brandt J, Mandiga P: Histology, Alveolar Cells. 2023. https://www.ncbi.nlm.nih.gov/books/NBK557542.. Meyer M, Jaspers I: Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2015, 308:L1189–201. 10.1152/ajplung.00028.2015 Johns D, Walters J, Walters H: Diagnosis and early detection of COPD using spirometry. 2014, 6:10.3978/j.issn.2072-1439.2014.08.18 Di Stefano A, Caramori G, Ricciardolo FLM, Capelli A, Adcock IM, Donner CF: Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy. 2004, 34:1156–67. 10.1111/j.1365-2222.2004.02030.x Qureshi H, Sharafkhaneh A, Hanania NA: Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Therapeutic Advances in Chronic Disease. 2014, 5:212–27. 10.1177/2040622314532862 Bollmeier SG, Hartmann AP: Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy. 2020, 77:259–68. 10.1093/ajhp/zxz306 Ucgun I, Metintas M, Moral H, Alatas F, Yildirim H, Erginel S: Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respiratory Medicine. 2006, 100:66–74. 10.1016/j.rmed.2005.04.005 Mani RK, Schmidt W, Lund LW, Herth FJF: Respiratory Dialysis for Avoidance of Intubation in Acute Exacerbation of COPD. ASAIO Journal. 2013, 59:675–8. 10.1097/mat.0000000000000004 Lu Y, Chang R, Yao J, Xu X, Teng Y, Cheng N: Effectiveness of long-term using statins in COPD – a network meta-analysis. Respir Res. 2019, 20:. 10.1186/s12931-019-0984-3 Jain MK, Ridker PM: Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms. Nat Rev Drug Discov. 2005, 4:977–87. 10.1038/nrd1901 Damkjaer M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N: Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study. COPD. 2021, Volume 16:579–89. 10.2147/copd.s296472 Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J: Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax. 2014, 70:33–40. 10.1136/thoraxjnl-2014-205795 Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T: The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature. CCR. 2017, 13:. 10.2174/1573403x13666170426104611 Graf J, Jörres RA, Lucke T, Nowak D, Vogelmeier CF, Ficker JH: Medical Treatment of COPD. Deutsches Ärzteblatt international. 2018. 10.3238/arztebl.2018.0599 Mathioudakis AG, Vestbo J, Singh D: Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine. 2020, 41:463–74. 10.1016/j.ccm.2020.05.005 Rabbat A, Guetta A, Lorut C, Lefebvre A, Roche N, Huchon G: Prise en charge des exacerbations aiguës de BPCO. Revue des Maladies Respiratoires. 2010, 27:939–53. 10.1016/j.rmr.2010.08.003 Wildman MJ, O’Dea J, Kostopoulou O, Tindall M, Walia S, Khan Z: Variation in intubation decisions for patients with chronic obstructive pulmonary disease in one critical care network. QJM: An International Journal of Medicine. 2003, 96:583–91. 10.1093/qjmed/hcg104 Ferrera MC, Labaki WW, Han MK: Advances in Chronic Obstructive Pulmonary Disease. Annu. Rev. Med. 2021, 72:119–34. 10.1146/annurev-med-080919-112707 Yayan J, Bald M, Franke K-J: No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years. IJGM. 2021, Volume 14:2883–92. 10.2147/ijgm.s309647 Barnes PJ: Alveolar Macrophages as Orchestrators of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2004, 1:59–70. 10.1081/copd-120028701